As of January 22, 2025, UCB (UCB.VI) has a market cap of $36.47 billion USD. According to our data, UCB is ranked No.550 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $36.47 B |
-3.73%
|
Dec 30, 2024 | $37.88 B |
145.97%
|
Dec 29, 2023 | $15.40 B |
7.23%
|
Dec 30, 2022 | $14.36 B |
-25.26%
|
Dec 30, 2021 | $19.22 B |
20.08%
|
Dec 30, 2020 | $16.00 B |
20.83%
|
Dec 30, 2019 | $13.24 B |
4.29%
|
Dec 31, 2018 | $12.70 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
AbbVie
ABBV
|
$300.53 B |
0.002 M
|
USA
|
Amgen
AMGN
|
$147.53 B |
0.002 M
|
USA
|
Biogen
BIIB
|
$20.80 B |
-0.001 M
|
USA
|
Bristol-Myers Squibb
BMY
|
$115.86 B |
0.003 M
|
USA
|
Eli Lilly
LLY
|
$676.92 B |
0.020 M
|
USA
|
Gilead Sciences
GILD
|
$116.07 B |
0.004 M
|
USA
|
GlaxoSmithKline
GSK
|
$68.38 B |
0.002 M
|
UK
|
Johnson & Johnson
JNJ
|
$347.78 B |
-0.005 M
|
USA
|
Merck
MRK
|
$242.59 B |
0.007 M
|
USA
|
Novartis
NVS
|
$197.43 B |
0.007 M
|
Switzerland
|
Pfizer
PFE
|
$148.34 B |
-0.006 M
|
USA
|
Sanofi
SNY
|
$128.55 B |
0.003 M
|
France
|
Takeda Pharmaceutical
TAK
|
$41.01 B |
-0.002 M
|
Japan
|
Teva Pharmaceutical Industries
TEVA
|
$25.08 B |
19.908 M
|
Israel
|
Market Cap | = | UCB.VI Stock Price | * | UCB.VI Shares Outstanding |
= | $192.11 | * | 0.19 B | |
= | $36.47 B |